Background
Glioblastoma multiforme (GBM) is associated with a poor prognosis and patients rely heavily on family caregivers for physical and emotional support. The capability and mental health of family caregivers may influence their ability to provide care and affect patient outcomes. We aimed to investigate whether caregivers’ anxiety, depressive symptoms, burden and mastery influenced survival in a sample of patients newly diagnosed with GBM.
Methods
Baseline data from caregiver-patient dyads participating in a NIH funded longitudinal study were used. Cox regression analyses were performed to determine whether caregiver anxiety (Profile of Mood States-Anxiety), depressive symptoms (Center for Epidemiologic Studies-Depression), burden (Caregiver Reaction Assessment), and feelings of mastery (Mastery Scale) predicted GBM patient survival time after controlling for known covariates (patient age, performance status, type of surgery, and postsurgical treatment).
Results
In total, 88 caregiver-patient dyads were included. Median overall survival for the sample was 14.5 months (range 0–88 months). After controlling for covariates, caregiver mastery was predictive of patient survival. With each unit increase in mastery, there was a 16.1% risk reduction of patient death (95% confidence interval: 0.771–0.913, P<0.001).
Conclusions
Our results are among the first to explore the impact of family caregiving for GBM patients’ outcomes. If these results are supported in other studies, providing neuro-oncology caregivers with more structured support and guidance in clinical practice have the potential to improve caregivers’ feelings of mastery, influencing patients’ wellbeing for the better.